Aurora Cannabis
Produces medical cannabis internationally while operating North American plant-propagation businesses.
Something off on this page? Send us feedback.
Profile
Produces, distributes, and sells medical cannabis in Canada and international markets, while consumer cannabis is limited in Canada. It also operates plant-propagation businesses added through the Thrive and Bevo acquisitions; international medical products include Farm Gas and Driftwood Diesel.
Produces, distributes, and sells medical cannabis in Canada and international markets, with consumer cannabis limited to Canada. Its cultivation and distribution footprint supports medical products including Farm Gas and Driftwood Diesel.
International medical markets are central to the operating model: listed products reach Germany, Poland, the United Kingdom, Canada, and Australia. Plant-propagation operations joined the structure through the Thrive and Bevo transactions, adding a second business line alongside cannabis.
Recent investments extend medical-cannabis capacity, including full ownership of MedReleaf Australia and the Safari Flower acquisition. The business depends on regulated medical-cannabis regimes and EU-GMP-certified cultivation and manufacturing capacity used to serve international markets.
Company facts
Categories
Key statistics
Year to date −7.8% · Average volume (30d) 1.7M
Analysts
Ratings
Target range
Latest analyst notes
No analyst notes in the last 24 months.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q1 FY27 | −$0.13 | −$0.05 | +64.6% | $47.4M | $47.6M | +0.2% | +3.56% |
| Jun 11, 2026Q4 FY26 | −$0.07 | $0.07 | +200.0% | $54.4M | $61.0M | +12.0% | −1.30% |
| Feb 4, 2026Q3 FY26 | $0.10 | $0.09 | −7.4% | $67.3M | $68.6M | +2.0% | −11.73% |
| Nov 5, 2025Q2 FY26 | $0.03 | $0.09 | +200.0% | $88.4M | $63.2M | −28.4% | −2.24% |
Financial highlights
| 12 quarters | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | $65.1M | $63.4M | $65.0M | $67.8M | $27.4M | $48.6M | |
| Gross profit | $15.8M | $56.8M | $23.2M | $33.5M | $13.1M | −$2.9M | |
| Operating income | −$21.9M | $26.5M | −$13.1M | $3.5M | — | −$34.1M | |
| Net income | −$17.7M | $22.8M | −$37.0M | $1.3M | −$41.0M | −$2.9M | |
| Diluted EPS | −$0.32 | $0.41 | −$0.65 | $0.02 | −$0.71 | −$0.05 | |
| Gross margin | 24.2% | 89.6% | 35.7% | 49.5% | 47.8% | -5.9% | |
| Operating margin | -33.6% | 41.8% | -20.2% | 5.1% | — | -70.2% |
Fiscal years (4-quarter sums)FY22 $162.4M · FY23 $161.0M · FY24 $194.0M · FY25 $246.9M · FY26 $223.6M
Revenue by geography · FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $107.3M · Total debt $16.3M · Total assets $446.8M · Shareholders' equity $379.4M
Dividends
No dividends on record.
Ownership
Shares outstanding 61.94M · Float 61.54M · 99.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Goldman Sachs Group Inc | 1.35M | 2.18% | 13F | Aug 14, 2026 |
| Toroso Investments, LLC | 1.26M | 2.04% | 13F | Aug 13, 2026 |
| Renaissance Technologies LLC | 785.0K | 1.27% | 13F | Aug 13, 2026 |
| National Bank of Canada /FI/ | 241.1K | 0.39% | 13F | Aug 10, 2026 |
| Morgan Stanley | 240.7K | 0.39% | 13F | Aug 13, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Tilray Brands
Global medical and adult-use cannabis supplier with broad Canadian formats
- Canopy Growth
Medical and adult-use cannabis supplier across Canada, Europe and Australia
- Cronos Group
Canadian and international cannabis brands spanning medical and adult use
- Organigram Global
Canadian indoor-grown medical and adult-use cannabis producer with EU reach
- Village Farms International
Canadian greenhouse cannabis producer with Pure Sunfarms and export capacity
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Aurora Cannabis | $4.01 | +0.25% | $248.4M | — | — | 1.2 | −26.5% |
| Tilray Brands | $4.59 | +0.17% | $513.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9900 | −1.88% | $421.9M | — | — | 0.8 | +8.4% |
| Cronos Group | $3.38 | +0.14% | $1.26B | 18.7 | 56.3 | 7.0 | +63.8% |
| Organigram Global | $1.20 | −1.99% | $171.0M | 2.7 | 49.6 | 0.7 | +43.3% |
| Village Farms International | $2.95 | +1.90% | $354.5M | 15.5 | 14.6 | 1.5 | +6.8% |
| Median | 15.5 | 49.6 | 0.8 | +25.5% |







